IMM-124E

N/A

Report date: 2024/03/08 17:48:47

Base Information

Drug NameIMM-124E
Drug Alias NameTravelanIMM-124EIMM122-I
ClassificationNatural product/Extract > Animal extractBiologics
Mechanisms of ActionImmunomodulatorsAnti-LPS
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsDiarrheaHepatitis, AlcoholicMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmuron
China Registration ClassN/A

Develop Information

Active CompaniesImmuron Ltd
Inactive CompaniesVirginia Commonwealth University
Active IndicationsDiarrhea
Inactive IndicationsHepatitis, AlcoholicMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A